• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性感染中新冠病毒(SARS-CoV-2)的可变进化速率。

Variable rates of SARS-CoV-2 evolution in chronic infections.

作者信息

Smith Ewan W, Hamilton William L, Warne Ben, Walker Elena R, Jahun Aminu S, Hosmillo Myra, Gupta Ravindra K, Goodfellow Ian, Gkrania-Klotsas Effrossyni, Török M Estée, Illingworth Christopher J R

机构信息

MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.

Department of Medicine, University of Cambridge, Cambridge, United Kingdom.

出版信息

PLoS Pathog. 2025 Apr 28;21(4):e1013109. doi: 10.1371/journal.ppat.1013109. eCollection 2025 Apr.

DOI:10.1371/journal.ppat.1013109
PMID:40294077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12061394/
Abstract

An important feature of the evolution of the SARS-CoV-2 virus has been the emergence of highly mutated novel variants, which are characterised by the gain of multiple mutations relative to viruses circulating in the general global population. Cases of chronic viral infection have been suggested as an explanation for this phenomenon, whereby an extended period of infection, with an increased rate of evolution, creates viruses with substantial genetic novelty. However, measuring a rate of evolution during chronic infection is made more difficult by the potential existence of compartmentalisation in the viral population, whereby the viruses in a host form distinct subpopulations. We here describe and apply a novel statistical method to study within-host virus evolution, identifying the minimum number of subpopulations required to explain sequence data observed from cases of chronic infection, and inferring rates for within-host viral evolution. Across nine cases of chronic SARS-CoV-2 infection in hospitalised patients we find that non-trivial population structure is relatively common, with five cases showing evidence of more than one viral population evolving independently within the host. The detection of non-trivial population structure was more common in severely immunocompromised individuals (p = 0.04, Fisher's Exact Test). We find cases of within-host evolution proceeding significantly faster, and significantly slower, than that of the global SARS-CoV-2 population, and of cases in which viral subpopulations in the same host have statistically distinguishable rates of evolution. Non-trivial population structure was associated with high rates of within-host evolution that were systematically underestimated by a more standard inference method.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒进化的一个重要特征是出现了高度变异的新型变体,其特征是相对于全球普通人群中传播的病毒而言获得了多个突变。慢性病毒感染病例被认为是这一现象的一个解释,即延长的感染期以及加快的进化速度产生了具有大量基因新异性的病毒。然而,由于病毒群体中可能存在区室化现象,即宿主中的病毒形成不同的亚群,这使得测量慢性感染期间的进化速度变得更加困难。我们在此描述并应用一种新颖的统计方法来研究宿主内病毒进化,确定解释从慢性感染病例中观察到的序列数据所需的最少亚群数量,并推断宿主内病毒进化的速率。在9例住院患者的慢性SARS-CoV-2感染病例中,我们发现非平凡的群体结构相对常见,有5例显示有多个病毒群体在宿主体内独立进化的证据。在严重免疫功能低下的个体中,检测到非平凡的群体结构更为常见(p = 0.04,Fisher精确检验)。我们发现宿主内进化的病例比全球SARS-CoV-2群体的进化速度显著更快和显著更慢,以及同一宿主内病毒亚群具有统计学上可区分的进化速率的病例。非平凡的群体结构与宿主内进化的高速度相关,而一种更标准的推断方法会系统性地低估这种高速度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/ad9e34b9c53d/ppat.1013109.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/96f5a84f13d5/ppat.1013109.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/30866b9eeab0/ppat.1013109.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/84405ecb3ceb/ppat.1013109.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/fc760eb86c96/ppat.1013109.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/357ac80adf29/ppat.1013109.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/1294e3b80d83/ppat.1013109.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/ad9e34b9c53d/ppat.1013109.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/96f5a84f13d5/ppat.1013109.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/30866b9eeab0/ppat.1013109.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/84405ecb3ceb/ppat.1013109.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/fc760eb86c96/ppat.1013109.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/357ac80adf29/ppat.1013109.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/1294e3b80d83/ppat.1013109.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/12061394/ad9e34b9c53d/ppat.1013109.g007.jpg

相似文献

1
Variable rates of SARS-CoV-2 evolution in chronic infections.慢性感染中新冠病毒(SARS-CoV-2)的可变进化速率。
PLoS Pathog. 2025 Apr 28;21(4):e1013109. doi: 10.1371/journal.ppat.1013109. eCollection 2025 Apr.
2
Prevalence of persistent SARS-CoV-2 in a large community surveillance study.大型社区监测研究中 SARS-CoV-2 的持续流行率。
Nature. 2024 Feb;626(8001):1094-1101. doi: 10.1038/s41586-024-07029-4. Epub 2024 Feb 21.
3
SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient.一名免疫功能低下患者长期感染期间的SARS-CoV-2宿主内进化
Int J Infect Dis. 2022 Sep;122:444-448. doi: 10.1016/j.ijid.2022.06.023. Epub 2022 Jun 18.
4
Virus Evolution in Prolonged Infections of Immunocompromised Individuals.免疫功能低下个体长期感染中的病毒进化
Clin Chem. 2025 Jan 3;71(1):109-118. doi: 10.1093/clinchem/hvae150.
5
Case reports of persistent SARS-CoV-2 infection outline within-host viral evolution in immunocompromised patients.病例报告显示,免疫功能低下患者的 SARS-CoV-2 持续感染概述了体内病毒进化。
Virol J. 2024 Sep 3;21(1):210. doi: 10.1186/s12985-024-02483-y.
6
Effect of molnupiravir on SARS-CoV-2 evolution in immunocompromised patients: a retrospective observational study.莫努匹韦对免疫功能低下患者中 SARS-CoV-2 进化的影响:一项回顾性观察研究。
Lancet Microbe. 2024 May;5(5):e452-e458. doi: 10.1016/S2666-5247(23)00393-2. Epub 2024 Mar 22.
7
Patterns of within-host genetic diversity in SARS-CoV-2.SARS-CoV-2 病毒在宿主内的遗传多样性模式。
Elife. 2021 Aug 13;10:e66857. doi: 10.7554/eLife.66857.
8
Secondary structure of the SARS-CoV-2 genome is predictive of nucleotide substitution frequency.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)基因组的二级结构可预测核苷酸替换频率。
Elife. 2025 Feb 28;13:RP98102. doi: 10.7554/eLife.98102.
9
Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma.SARS-CoV-2 在患有非霍奇金淋巴瘤的免疫功能低下患者中的长期进化。
mSphere. 2021 Aug 25;6(4):e0024421. doi: 10.1128/mSphere.00244-21. Epub 2021 Jul 28.
10
SARS-CoV-2 population dynamics in immunocompetent individuals in a closed transmission chain shows genomic diversity over the course of infection.在封闭传播链中免疫功能正常个体的新冠病毒种群动态显示,在感染过程中存在基因组多样性。
Genome Med. 2024 Jul 16;16(1):89. doi: 10.1186/s13073-024-01360-1.

引用本文的文献

1
Immune pressure is key to understanding observed patterns of respiratory virus evolution in prolonged infections.免疫压力是理解在长期感染中观察到的呼吸道病毒进化模式的关键。
Virus Evol. 2025 Jul 21;11(1):veaf054. doi: 10.1093/ve/veaf054. eCollection 2025.
2
Diverse patterns of intra-host genetic diversity in chronically infected SARS-CoV-2 patients.慢性感染的新冠病毒患者体内宿主基因多样性的不同模式
Virus Evol. 2025 Jun 15;11(1):veaf047. doi: 10.1093/ve/veaf047. eCollection 2025.

本文引用的文献

1
Genetic consequences of effective and suboptimal dosing with mutagenic drugs in a hamster model of SARS-CoV-2 infection.在新冠病毒(SARS-CoV-2)感染的仓鼠模型中,使用致突变药物进行有效和次优剂量给药的遗传后果。
Virus Evol. 2024 Jan 4;10(1):veae001. doi: 10.1093/ve/veae001. eCollection 2024.
2
Prevalence of persistent SARS-CoV-2 in a large community surveillance study.大型社区监测研究中 SARS-CoV-2 的持续流行率。
Nature. 2024 Feb;626(8001):1094-1101. doi: 10.1038/s41586-024-07029-4. Epub 2024 Feb 21.
3
Persistent SARS-CoV-2 infection: significance and implications.
持续的 SARS-CoV-2 感染:意义和影响。
Lancet Infect Dis. 2024 Jul;24(7):e453-e462. doi: 10.1016/S1473-3099(23)00815-0. Epub 2024 Feb 7.
4
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency.SARS-CoV-2 病毒清除和演变因免疫缺陷的类型和严重程度而异。
Sci Transl Med. 2024 Jan 24;16(731):eadk1599. doi: 10.1126/scitranslmed.adk1599.
5
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes.全球 SARS-CoV-2 基因组中与莫努匹韦相关的突变特征。
Nature. 2023 Nov;623(7987):594-600. doi: 10.1038/s41586-023-06649-6. Epub 2023 Sep 25.
6
Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual.一名持续感染、免疫功能低下个体中出现全球独特的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白E484T单克隆抗体逃逸突变的演变过程
Virus Evol. 2022 Nov 5;9(2):veac104. doi: 10.1093/ve/veac104. eCollection 2023.
7
The evolution of SARS-CoV-2.严重急性呼吸综合征冠状病毒2的进化
Nat Rev Microbiol. 2023 Jun;21(6):361-379. doi: 10.1038/s41579-023-00878-2. Epub 2023 Apr 5.
8
Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection.慢性感染期间加速 SARS-CoV-2 宿主内进化导致不同基因型。
Cell Rep Med. 2023 Feb 21;4(2):100943. doi: 10.1016/j.xcrm.2023.100943. Epub 2023 Jan 27.
9
SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19.SARS-CoV-2 在长期 COVID-19 期间逃避细胞毒性 T 细胞。
Nat Commun. 2023 Jan 10;14(1):149. doi: 10.1038/s41467-022-34033-x.
10
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK.英国新冠病毒B.1.1.7谱系的起源与分子进化
Virus Evol. 2022 Aug 26;8(2):veac080. doi: 10.1093/ve/veac080. eCollection 2022.